Livzon Pharmaceutical Group Incorporated operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Livzon Pharmaceutical Group Incorporated with three other
companies in this sector in China:
North China Pharmaceutical, Limited
sales of 8.08 billion Chinese Renmimbi [US$1.20 billion]
of which 43%
was Chemical Preparation Medicine),
Huapont-Nutrichem Co Ltd
(7.09 billion Chinese Renmimbi [US$1.05 billion]
of which 68%
was Agricultural Business), and
Chongqing Taiji Industry (Group)
(7.78 billion Chinese Renmimbi [US$1.15 billion]
of which 52%
During the year ended December of 2016, sales at
Livzon Pharmaceutical Group Incorporated were 7.65 billion Chinese Renmimbi (US$1.13 billion).
increase of 15.5%
versus 2015, when the company's sales were 6.62 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Livzon Pharmaceutical Group Incorporated
(and since 2011, sales have increased a total of 142%).
Sales of Western Medicine saw an increase
23.4% in 2016, from
2.58 billion Chinese Renmimbi to 3.19 billion Chinese Renmimbi.
Not all segments of Livzon Pharmaceutical Group Incorporated experienced an increase in sales in 2016:
sales of Other fell 75.0% to 1.43 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).
Livzon Pharmaceutical Group Incorporated also experienced decreases in sales in
Other Operatings (down 66.2% to 35.11 million Chinese Renmimbi)